YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
Xiangyuan LuoMengdie CaoFan GaoXing-Xing HePublished in: Experimental hematology & oncology (2021)
YTHDF1 contributes to the progression of HCC by activating PI3K/AKT/mTOR signaling pathway and inducing EMT.